SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
DMAC
--
0.00%
--
80 Biggest Movers From Friday
Gainers Berkeley Lights, Inc. (NASDAQ: BLI) shares jumped 197.5% to close at $65.45 on Friday after the company priced its 8.1 million share IPO at $22 per share.
Benzinga · 07/20 09:11
The Daily Biotech Pulse: Eloxx Resumes Cystic Fibrosis Study, Rexahn's Reverse Merger, Ultragenyx, Epizyme Await FDA Decisions
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 17)
Benzinga · 06/18 12:34
Hedge Funds Getting Interested In DiaMedica Therapeutics Inc. (DMAC)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. Insider Monkey finished processing 821 13F filings submitted by hedge funds and prominent investors. These fi
Insider Monkey · 06/11 00:16
DiaMedica Therapeutics to Present at the 17th Annual Craig-Hallum Institutional Investor Conference on May 27, 2020
DiaMedica Therapeutics Inc. (Nasdaq: DMAC) today announced that it will be participating in the 17th Annual Craig-Hallum Institutional Investor Conference being held virtually on Wednesday, May 27, 2020. Management will be available to participate in one-on-on
Business Wire · 05/19 20:42
Craig-Hallum Maintains Buy on DiaMedica Therapeutics, Raises Price Target to $15
Craig-Hallum maintains DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy and raises the price target from $10 to $15.
Benzinga · 05/15 15:47
60 Biggest Movers From Yesterday
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares surged 71.1% to close at $15.21 on Thursday after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
Benzinga · 05/15 08:53
42 Stocks Moving In Thursday's Mid-Day Session
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) jumped 53.4% to $13.64 after the company announced it has received FDA emergency use authorization for its coronavirus diagnostic assay kit.
Benzinga · 05/14 18:57
DiaMedica Therapeutics Inc. 2020 Q1 - Results - Earnings Call Presentation
Seeking Alpha - Article · 05/14 16:46
AIM, CLLS, CRK and CGEN among midday movers
Seeking Alpha - Article · 05/14 16:40
DiaMedica Therapeutics Inc.'s (DMAC) CEO Rick Pauls on Q1 2020 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 05/14 16:35
DiaMedica Therapeutics EPS beats by $0.09
DiaMedica Therapeutics (NASDAQ:DMAC): Q1 GAAP EPS of -$0.19 beats by $0.09. Cash, equivalents and marketable securities of $12.6M (+59.5% Q/Q) Press Releas
seekingalpha · 05/14 01:44
DiaMedica Announces Positive Results in Top-Line Data From the Phase II ReMEDy Acute Ischemic Stroke Study
Business Wire · 05/13 21:41
DiaMedica Announces Positive Results in Top-Line Data from the Phase II ReMEDy Acute Ischemic Stroke Study and Provides a Business Update and First Quarter 2020 Financial Results
Business Wire · 05/13 21:40
DiaMedica's DM199 meets safety objective in mid-stage stroke study
Seeking Alpha - Article · 05/13 21:05
DiaMedica Therapeutics Q1 EPS $(0.190) Up From $(0.270) YoY
DiaMedica Therapeutics (NASDAQ:DMAC) reported quarterly losses of $(0.190) per share. This is a 29.63 percent increase over losses of $(0.270) per share from the same period last year.
Benzinga · 05/13 20:42
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12)
Benzinga · 05/13 11:40
The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight
The smid-cap biotech earnings deluge hit Wall Street in the week ended May 9, positively impacting the stocks in the sector. The iShares NASDAQ Biotechnology Index (NASDAQ: IBB) gained about 6% for the week.
Benzinga · 05/10 19:40
DiaMedica Therapeutics to Report First Quarter 2020 Financial Results and Provide a Business Update May 14, 2020
Business Wire · 05/07 21:30
DiaMedica Therapeutics to Present Research at National Kidney Foundation 2020 Spring Clinical Meetings Live Virtual Conference
Business Wire · 03/26 14:12
DiaMedica Therapeutics Inc. (DMAC) CEO Rick Pauls on Q4 2019 Results - Earnings Call Transcript
Seeking Alpha - Transcript · 03/24 14:48